Table 1 |
|||||
| Correlation between MET copy number and parameters | |||||
| MET copy number | |||||
| Case no. (%) | >3 copies (%) | P | Loss (%) | P | |
| Gender | |||||
| Male | 12 (43) | 2 (40) | 0.89 | 3 (38) | 0.72 |
| Female | 16 (57) | 3 (60) | 5 (62) | ||
| Age (years) | |||||
| ≥60 | 8 (29) | 1 (20) | 0.65 | 2 (25) | 0.8 |
| <60 | 20 (71) | 4 (80) | 6 (75) | ||
| B symptom | |||||
| Present | 6 (22) | 1 (20) | 0.9 | 0 (0) | 0.08 |
| Absent | 21 (78) | 4 (80) | 8 (100) | ||
| Perforation | |||||
| Present | 6 (21) | 3 (60) | 0.02 | 1 (13) | 0.48 |
| Absent | 22 (79) | 2 (40) | 7 (87) | ||
| Ann Arbor stage | |||||
| I or II | 23 (85) | 5 (100) | 0.31 | 7 (87) | 0.83 |
| III or IV | 4 (15) | 0 (0) | 1 (13) | ||
| Immunophenotype | |||||
| GCB | 7 (25) | 1 (20) | 0.78 | 3 (38) | 0.34 |
| Non-GCB | 21 (75) | 4 (80) | 5 (62) | ||
Huang and Chuang Diagnostic Pathology 2013 8:16 doi:10.1186/1746-1596-8-16
